Patent Myth Resources

Publish Date
Issue Briefs
Addressing Patent Myths

Activist groups routinely accuse companies of “abusing” the patent system by engaging in practices such as “royalty stacking,” “patent evergreening,” “product hopping,”...

Council for Innovation Promotion
Fact Check: House Judiciary Subcommittee on the ETHIC Act

The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet recently held a hearing titled “Medicines and IP: Balancing...

Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: Terminal Disclaimers
Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: The Eliminating Thickets to Increase Competition (ETHIC) Act
Council for Innovation Promotion
Why C4IP Opposes the ETHIC Act (S. 2276)

The Eliminating Thickets to Increase Competition (ETHIC) Act aims to eliminate so-called “patent thickets” in the prescription drug market — when companies...

Council for Innovation Promotion
Fact Check: Debunking the Patent “Evergreening” Myth

On April 16, the R Street Institute hosted a congressional briefing entitled “The Hidden Tax: How Bad Patents Drive Up Drug Prices...

Council for Innovation Promotion
Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist

Congress is considering a bill, the Eliminating Thickets to Increase Competition (ETHIC) Act, that would undermine innovation by preventing patent owners from...

Council for Innovation Promotion
Debunking common myths in the SEP patent pool debate

Patent pools are a time-tested approach to licensing standard-essential patents, also known as SEPs. These collaborative arrangements allow implementers to conveniently obtain...

Council for Innovation Promotion
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

Council for Innovation Promotion
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

Council for Innovation Promotion
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology
Council for Innovation Promotion
Blog:

Blog, Fact Checks:

Fact Check: House Judiciary Subcommittee on the ETHIC Act,

07/30/2026

Resources:

Resources:

Myths vs. Facts: Terminal Disclaimers,

05/29/2026

Resources:

Resources:

Myths vs. Facts: The Eliminating Thickets to Increase Competition (ETHIC) Act,

05/29/2026

Blog:

Blog:

Why C4IP Opposes the ETHIC Act (S. 2276),

05/29/2026

Blog:

Blog, Fact Checks:

Fact Check: Debunking the Patent “Evergreening” Myth,

05/28/2026

Blog:

Blog, Fact Checks:

Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist,

04/17/2026

Blog:

Blog:

Debunking common myths in the SEP patent pool debate,

01/28/2026

Blog:

Blog, Fact Checks:

Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”,

01/16/2026

Blog:

Blog, Fact Checks:

Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.,

12/04/2025

Blog:

Blog, Fact Checks:

Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”,

11/21/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025

Scroll to Top